Specifically Increased Rate of Infections in Children Post Measles in a High Resource Setting

Bühl, Daniel; Staudacher, Olga; Santibanez, Sabine; Rossi, Rainer; Girschick, Hermann; Stephan, Volker; Schmidt, Beatrix; Hundsdoerfer, Patrick; Moers, Arpad von; Lange, Michael; Barker, Michael; Mall, Marcus; Heininger, Ulrich; Matysiak‐Klose, Dorothea; Mankertz, Annette; Bernuth, Horst von

doi:10.3389/fped.2022.896086

Cited by 1 publication

(1 citation statement)

References 28 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Measles immunity is relevant since a transient immunosuppression with increased susceptibility to infections has been described even in healthy children after infection [ 47 ]. Higher measles titres may protect against infection, but at least minimise disease severity, similar to other infectious diseases [ 48 , 49 ].…”

Section: Discussionmentioning

confidence: 99%

Diminished measles immunity after paediatric liver transplantation—A retrospective, single-centre, cross-sectional analysis

Laue,

Junge,

Leiskau

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Liver transplantation in childhood has an excellent long-term outcome, but is associated with a long-term risk of infection. Measles is a vaccine-preventable infection, with case series describing severe courses with graft rejection, mechanical ventilation and even death in liver transplant recipients. Since about 30% of liver transplanted children receive liver transplants in their first year of life, not all have reached the recommended age for live vaccinations. On the contrary, live vaccines are contraindicated after transplantation. In addition, vaccination response is poorer in individuals with liver disease compared to healthy children. This retrospective, single-centre, cross-sectional study examines measles immunity in paediatric liver transplant recipients before and after transplantation. Vaccination records of 239 patients, followed up at Hannover Medical School between January 2021 and December 2022 were analysed. Twenty eight children were excluded due to stem cell transplantation, regular immunoglobulin substitution or measles vaccination after transplantation. More than 55% of all 211 children analysed and 75% of all those vaccinated at least once are measles seropositive after transplantation—48% after one and 84% after two vaccinations—which is less than in healthy individuals. Interestingly, 26% of unvaccinated children also showed measles antibodies and about 5–15% of vaccinated patients who were seronegative at the time of transplantation were seropositive afterwards, both possibly through infection. In multivariable Cox proportional hazards regression, the number of vaccinations (HR 4.30 [95% CI 2.09–8.83], p<0.001), seropositivity before transplantation (HR 2.38 [95% CI 1.07–5.30], p = 0.034) and higher age at time of first vaccination (HR 11.5 [95% CI 6.92–19.1], p<0.001) are independently associated with measles immunity after transplantation. In contrast, older age at testing is inversely associated (HR 0.09 [95% CI 0.06–0.15], p<0.001), indicating a loss of immunity. Vaccination in the first year of life does not pose a risk of non-immunity. The underlying liver disease influences the level of measles titres of twice-vaccinated patients; those with acute liver failure being the lowest compared to children with metabolic disease. In summary, vaccine response is poorer in children with liver disease. Liver transplant candidates should be vaccinated before transplantation even if this is earlier in the first year of life. Checking measles IgG and re-vaccinating seronegative patients may help to achieve immunity after transplantation.

show abstract

Section: Discussionmentioning

confidence: 99%